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Summary.-The cytotoxic effects in vivo of single doses of either adriamycin (ADM),
1-p-D-arabinofuranosylcytosine (Ara-C), bleomycin (BLM), cis-diamminedichloro-
platinum (II) (cis-DDP), or cyclophosphamide (CY) on murine fibrosarcoma (FSa)
cell populations were determined. Tumour cells were separated and synchronized by
centrifugal elutriation. Viable tumour cells from selected elutriator fractions were
then injected i.v. into whole-body-irradiated mice. Twenty minutes later selected
doses of ADM, Ara-C, BLM, cis-DDP or CY were administered to selected groups of
these animals. Fourteen days later the mice were killed. Killing of injected tumour
cells by each of the chemotherapeutic agents was evidenced by a reduction in the lung
colonies per cell injected in treated animals. Under these conditions the response of
FSa cells in vivo to the 5 drugs tested differed both qualitatively and quantitatively.
Ara-C was S-phase-specific in toxicity. ADM, BLM, and cis-DDP were preferentially
toxic to S, G2+M and G1 cells respectively. CY, a drug requiring bioactivation to
form alkylating metabolites, was found to be equally toxic to G1 and G2+M enriched
populations, but less effective in killing cell populations enriched with early-S cells.
KNOWLEDGE of the differential cyto-
toxicity of drugs to cells in various phases
of the cell cycle is extremely important to
the design of chemotherapy protocols.
Such studies have most frequently been
carried out in vitro, using cultured cell
lines. While this approach has given rise
to information, many difficulties exist in
relating these data to the complex in vivo
situation (Valeriote & van Putten, 1975).
In vivo studies have been made, but they
generally involve the use of two or more
cytotoxic agents. A partial synchrony of
"target" cells is induced by first exposing
the host animal to a known phase-specific
agent such as hydroxyurea (Madoc-Jones
& Mauro, 1970). At varying times after-
wards, a second agent is administered and
its effects are monitored. The difficulty
with this approach, however, is in discern-
ing whether the response ofthe cells to the
second agent is perturbed in any way by
exposure to the first.
In a recent communication we described
a procedure for testing in vivo the phase-
specific cytotoxicity of chemotherapeutic
agents (Grdina et al., 1979). The method is
based on the separation and synchroniza-
tion of tumour cells by centrifugal elutria-
tion (Grdina et al., 1978a). Cells enriched
in the various phases of the cell cycle (i.e.
the "target" populations) are injected i.v.
into mice. At selected times later, the drug
to be tested is administered either i.v., i.p.
or s.c. With appropriate controls, the
number of lung colonies formed reflects
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the phase-specific cytotoxicity of the test
agent. This procedure is advantageous in
that it is applicable to testing drugs which
require bioactivation. Additionally, rela-
tively large numbers of cells can be
separated, synchronized and recovered
without loss ofviability.
In this communication we describe the
cytotoxic effects of adriamycin (ADM),
1-P-D-arabinofuranosylcytosine (Ara-C),
bleomycin (BLM), cis-diamminedichloro-
platinum (II) (cis-DDP) and cyclophos-
phamide (CY) on synchronized murine
fibrosarcoma (FSa) cells lodged in the
lungs of specific-pathogen-free C3Hf/Kam
mice. The tumour cells were separated by
centrifugal elutriation and characterized
with respect to cell-stage distribution by
flow microfluorometry (FMF).
MATERIALS AND METHODS
Preparation of tumour cells. The tumour
and cell-separation systems have been de-
scribed in detail elsewhere (Grdina et al.,
1979). Briefly, tumour-source material was
derived from 6th generation isotransplants of
a methylcholanthrene-induced murine fibro-
sarcoma (Suit & Suchato, 1967). Ten-twelve-
week-old female C3Hf/Kam mice from our
specific-pathogen-free breeding colony were
used. Single-cell suspensions were obtained
by mincing and trypsinization (Grdina et al.,
1975). Cell viability was determined by phase-
contrast microscopy and was routinely
>9500. Tumour cells derived in this manner
were then incubated in vitro for 48 h before
centrifugal elutriation to improve synchrony
(Grdina et al., 1978a).
Cell separation by centrifugal elutriation.-
Tumour cells were separated under sterile
conditions using a Beckman JE-6 elutriator
rotor (Grdina et al., 1978a). The rotor cham-
ber and associated tubing were sterilized by
pumping 70% ethanolthroughout the system.
The ethanol was allowed to remain in the
system overnight. Before use, ethanol was
removed and sterile Solution A (8-0 g NaCl,
0 4 g KCI, 1 0 g glucose, and 0 35 g NaHCO3
in 1 1 H20) was used to rinse out the system.
The separation medium consisted of modified
McCoy's 5A (Humphrey et al., 1970) supple-
mented with 5% foetal calf serum containing
DNase (Deoxyribonuclease 1; Sigma Chemical
Co., St Louis, MO) at a final concentration of
0 1 mg/ml and 5mM 2-naphthol 6-8 disulph-
onic acid to reduce cell clumping (Shortman,
1973). All separations were performed at 4°C.
During separation the rotor speed was set at
1525 rev/min and the flow rates were varied
by equal increments from 5-4 to 27-4 ml/min.
Routinely, 2 x 108 cells were separated.
Twelve fractions were collected and then
stored at 4°C. Cells collected in each fraction
were counted by haemacytometer and by
Coulter counter (model ZBI; Coulter Elec-
tronics, Hialeah, FL), and their volume dis-
tributions determined with a multichannel
analyser (Channelyzer II; Coulter Elec-
tronics). The modal volume was designated as
the volume corresponding to the modal
channel number of the volume distribution
of each sample (Grdina et al., 1978a). The
DNA content ofindividual cells in suspension
was determined by flow microfluorometry
(FMF) using an ICP II flow cytometer
(Phywe Co., Gottingen, Germany). Cells were
stained with mithramycin (Grdina et al.,
1978a) and the resultant histograms of DNA
fluorescence were computer analysed (John-
ston et al., 1978).
Lung colony assay.-The colony-forming
efficiency (CFE) of FSa cells was determined
by a lung colony assay (Hill & Bush, 1969).
To maximize CFE, recipient mice, with their
hind legs shielded, were whole-body irradiated
with 10 Gy 24 h before use. These mice were
injected with 1-5 x 104 viable FSa cells from
each of the elutriator fractions, or an un-
separated control population (USC) along
with 2 x 106 heavily irradiated (HIR; 100 Gy)
FSa tumour cells. The HIR cells were not
separated by centrifugal elutriation. Fourteen
days later the mice were killed, their lungs
removed, the lobes separated and fixed in
Bouin's solution, and tumour colonies
counted.
Drug testing in vivo.-The drugs used in
this study were obtained from the following
sources: ADM, Adria Laboratories, Wilming-
ton, DE; Ara-C, Upjohn, Kalamazoo, MI;
BLM, Bristol Laboratories, Syracuse, NY;
cis-DDP, Division of Cancer Treatment,
National Cancer Institute, National Insti-
tutes of Health, Bethesda, MD; and CY,
Mead Johnson, Evansville, IN. Pheno-
barbital was obtained from Wyeth Labora-
tories, Inc., Philadelphia, PA, and adminis-
tered i.p. at a dose of 40 jtg/g twice daily for
5 days before treatment of animals with CY
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(Peters & Mason, 1977). Stock solutions of
drugs were made up immediately before use
in sterile water. Twenty minutes after the i.v.
injection of viable FSa cells from each of the
elutriator fractions and an unseparated con-
trol population into recipient mice, selected
groups of these animals were injected with
either ADM (10 mg/kg, i.v. or 5 mg/kg i.p.),
Ara-C (50 mg/kg, i.p.), BLM (15 mg/kg, s.c.)
or cis-DDP (4 mg/kg, i.v.). In addition, CY
(200 mg/kg, i.v.) was injected into mice pre-
viously treated with phenobarbital. Addi-
tional groups of mice injected with viable
FSa cells, and phenobarbital in the case of
CY experiments, remained untreated as con-
trols. Under these conditions, FSa cells from
the various elutriator fractions are equally
retained in the lungs ofthe recipient animals,
and over 95?/O of the cells are present in the
lungs 20 min after injection (Grdina et al.,
1978b). Drug doses and routes of administra-
tion were chosen which allowed for sufficient
expression of tumour cell killing but mini-
mized toxic effects to the animals used in the
experiments.
RESULTS
A variety of chemotherapeutic agents
have been tested in vivo against murine
fibrosarcoma cell populations synchron-
ized by centrifugal elutriation. Presented
in Fig. 1 is a representative sedimentation
profile, describing the relationship be-
tween modal cell volume and the number
of cells recovered in each elutriator frac-
tion. Cell recovery ranged from 85 to 95%.
Cell viability, as determined by phase-
contrast microscopy, was routinely > 95%
for cells collected in Fractions (F) 3-11.
Fl and F2 were discarded because they
contained subcellular debris and damaged
cells. F12 and F13 contained mixtures of
large and small cells, as well as small
clumps of cells washed out of the rotor at
the end of the run; these fractions were
therefore also discarded. Using the method
of flow microfluorometry, no non-tumour
cells were detected in any ofthe fractions.
These cells had been eliminated from the
tumour population by incubating the
tumour suspension for 48 h in vitro before
separation (Grdina et al., 1978a).
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FiG. 1. A representative sedimentation
profile of FSa tumour cells separated by
centrifugal elutriation. The number of
cells ( 0) and the corresponding
modal cell volume (A---A) are plotted
as a function of sedimentation velocity and
fraction number.
The colony-forming efficiency (CFE) of
untreated cell populations varied between
experiments from 1 to 3% (i.e. an average
of 50-150 colonies per animal). Within
each experiment, however, no appreciable
difference in CFE was observed between
the elutriated control groups. All experi-
ments were repeated at least 3 times, and
representative data are presented in each
ofthe figures.
The cytotoxic effectiveness of ADM was
tested in vivo on an unseparated control
(USC) population and elutriator-synchron-
ized FSa populations lodged in the lungs of
test animals. For comparison, the drug
was administered either i.p. at 5 mg/kg or
i.v. at 10 mg/kg. Under either condition,
cell killing was seen in all cell fractions,
with the greatest reduction in CFE for
cells collected in F9 (see Fig. 2). This
elutriator fraction contained 80% S-phase
cells.
For comparison, the CFE after expo-
sure in vivo to ADM, Ara-C, BLM and cis-
DDP, as well as the percentage of cells in
the various phases ofthe cell cycle for each
of the elutriated fractions collected, are
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FIG. 2. The percent of surviving FSa cells
after exposure in vivo to adriamycin (ADM)
at a dose of either 5 mg/kg, i.p. (0), or
10 mg/kg, i.v. (@), is plotted as a function
of elutriation fraction number. USC
unseparated cells. The vertical bars rep-
resent 1 standard error of the mean.
summarized in Fig. 3. Ara-C was found to
be most toxic to S-enriched tumour popu-
lations in vivo, as evidenced by the re-
duced CFE of cells in F7, F8 and F9.
These populations contained 63, 72 and
80% S cells, respectively. FSa cells in FIO
and F 11, however, were found to be most
sensitive to BLM administered s.c. These
fractions contained 84% and 90% G2+M
cells respectively. Finally, cis-DDP ad-
ministered i.v. was found to be most cyto-
toxic to cells in F2-4. These contained
primarily G1 cells (94-65%). Since no lung
colonies were observed in treated animals
injected with F2 and F3 cells, these points
could not be included in the figure.
Each of the agents described so far is
cytotoxic under in vitro conditions and
has been extensively characterized using
in vitro cell systems. Cyclophosphamide,
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FIGe. 3.-A comparison of the percentage sur-
viving FSa cells after an exposure in vivo
to either 10 mg/kg i.v. adriamycin (ADM,
A A), 50 mg/kg i.p. Ara-C (0 0),
15 mg/kg s.c. bleomycin (BLM, *
or 4 mg/kg i.v. cis-diamminedichloroplati-
num (II) (cis-DDP, A- A) (top), and
the percentage of cells distributed among
the various cell cycle phases (bottom)
(M GI, 0 8, V G2) are plotted as a function
of elutriator fraction number. The vertical
bars represent 1 standard error ofthe mean.
however, requires biotransformation by
microsomal mixed-function oxidases to
exert its cytotoxic effect (Brock &
Hohorst, 1967). In addition, phenobarbital
has been found to accelerate the biotrans-
formation of CY to its active form
(Donelli et al., 1976; Peters & Mason,
1977). The cytotoxic effect of CY on FSa
cells lodged in the lungs of phenobarbital-
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FIG. 4. The percentage surviving FSa cells
after an exposure in vivo to cyclophos-
phamide (CY) at a dose of 200 mg/kg i.v.,
is plotted as a function of elutriator frac-
tion number. Animals were pretreated with
plenobarbital at a dose of 40 Itg/g twice
daily eacl day for 5 days before admini-
stration of CY. USC = unseparated cells.
The vertical bars represent the s.e.
treated animals is presented in Fig. 4. CY
was more toxic to cells in G1 (F3-F5) and
G2+M (F9-F11) than to S cells in the
intermediate fractions (F6 and F7). Simi-
lar results were obtained using mice not
pretreated with phenobarbital.
DISCUSSION
In an earlier report we described in
detail a procedure by which chemo-
therapeutic agents could be characterized
in vivo with respect to phase specificity in
cell killing (Grdina et al., 1979). In par-
ticular, we chose hydroxyurea for initial
investigation, because it had been well
characterized with respect to its phase-
specific toxicity to S cells. We have now
further characterized this system with
respect to agents which are known to
differ from each other in their phase-
specific or preferential toxicity to cells, one
of which must be bioactivated in order to
exert its cytotoxicity.
ADM was chosen because it is a well
48
characterized anthracycline antibiotic
known to be effective against many animal
and tumour systems. It has been observed
that while it is cytotoxic for cells in all
phases of the cell cycle, it is most toxic to
cells in S (Kim & Kim, 1972). Our results
agree with these findings. ADM cyto-
toxicity in vivo, as evidenced by a reduc-
tion in the number of lung colonies in
treated mice, was greatest for FSa cell
populations most enriched with S cells
(see Fig. 2). This effect, though differing
in magnitude, was similar for the two
doses and routes of injection used.
Ara-C is a known S-specific agent
(Skipper et al., 1967; Momparler, 1974).
As shown in Fig. 3, cell killing correlated
well with the percentage of S cells in each
fraction. BLM, an agent reported to be
most effective against G2 and M cells
(Barranco & Humphrey, 1971; Drewinko
& Barlogie, 1976) was found to be most
toxic to G2+M FSa cells collected in F10
and Fll.
Cis-DDP was included in this study
because it has been demonstrated under
in vitro conditions to be preferentially
cytotoxic to G1 (Drewinko et al., 1973;
Fraval & Roberts, 1979). As shown in
Fig. 3, cis-DDP was most toxic to the G1-
enriched FSa population in F3. In a recent
report, centrifugal elutriation was used to
separate and synchronize Chinese hamster
ovary (CHO) cells in order to characterize
the cycle-dependent cytotoxicity of
selected chemotherapeutic agents in vitro
(Meyn et al., 1980). CHO cells were ob-
served in this study to be most sensitive
to cis-DDP in G1, ADM and Ara-C in 5,
and BLM in G2+M.
There is excellent agreement between
data derived from established in vitro
methods and those presented here con-
cerning the cytotoxic activities of ADM,
Ara-C, BLM and cis-DDP. These agents
have been demonstrated to exert similar
cell-cycle phase-dependent toxicity under
both in vitro and in vivo conditions. The
in vivo method has the advantage that it
permits the direct characterization of
agents which require bioactivation to
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become effective. For this reason, cyclo-
phosphamide was chosen for study. CY is
a potent antineoplastic agent which must
be metabolized, primarily by microsomal
enzymes in the liver, to produce alkylating
metabolites (Brock & Hohorst, 1967). To
accelerate this effect, liver microsomal
enzymes can be stimulated by pheno-
barbital (Donelli et al., 1976; Peters &
Mason, 1977). Alkylating agents are
known to be more toxic to G1 and M cells
than to S cells (Bhuyan, 1977). Results
presented in Fig. 4 indicate that FSa
populations enriched with S cells (i.e. F6
and F7) were less sensitive to CY toxicity
than cells from the other fractions. These
results were confirmed in 3 separate
experiments.
In conclusion, we have characterized in
vivo the cell-cycle phase-specific effects of
a variety of chemotherapeutic agents
currently used in the treatment of malig-
nant disease. The method described in
this communication can also be applied to
include the separation and synchroniza-
tion of FSa cells grown as pulmonary
nodules in mice, without the requirement
of a preseparation incubation in vitro
(Grdina, 1980). Data acquired in this
manner, however, must be interpreted
with respect to the pharmacological pro-
perties ofthe agents tested and the animal
system used. Chemotherapeutic agents
can thus be routinely and rapidly evalu-
ated under in vivo conditions with respect
to their phase-specificity in cell killing,
effect on cell kinetics, and toxicity to the
host animal.
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